Payoneer Global Inc.

Payoneer is a cross-border payments platform, but the operating story doesn't matter much for holders right now — the equity is priced against a signed cash acquisition. On June 15, Nuvei announced a definitive agreement to buy Payoneer at $7.40 per share in all-cash consideration, valuing the equity at about $2.75B — roughly a 44% premium to the pre-announcement close. Closing is expected mid-2027, subject to shareholder vote and antitrust review.

What this means for a retail read:

• The current $7.16 quote sits about 3% below the $7.40 deal price. That is a normal 'merger-arb' discount reflecting time-value-of-money over roughly a year and the probability of any regulatory or shareholder blockage. It is not a signal that the business is worth less.
• Termination fees are two-sided: $89M payable by Payoneer in specified breakup scenarios and $165M by Nuvei if it fails to close as agreed. Higher reverse-termination fees are the standard way to make buyers' financing risk visible.
• The 'Ademi investigating a fair price' press release is boilerplate — those firms send one out on essentially every take-private and rarely move deal terms.

The underlying operating results, for context:

• Most recent quarter did $262M in revenue with about 6 cents EPS versus a 4-cent estimate — steady, not exciting, and consistent with the trailing four prints.
• The Q2 report on August 6 will be reported into the deal window and will focus more on customer retention and cross-border volumes than on setting a new equity level. Its main job is to confirm nothing operationally derails the deal calendar.

Bottom line: this is a merger-arb setup now. What matters from here is regulatory clearance timing, the shareholder vote, and any competing bid — none of which are on the table today.